← Leaderboards
Brian D. Gray
Molecular Targeting Technologies, Inc.
$349,996
Attributed
$349,996
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2017–18$500K$375K$250K$125K$0
'17
'18
Funding mix
By agency
NIH$349,996 · 1
By mechanism
N43$349,996 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Tumor Markers”
- Leonard Freedman · Leidos Biomedical Research, Inc.$291,160,289
- Lynn Briscoe · Leidos Biomedical Research, Inc.$116,524,368
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,936,170
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$17,454,417
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$16,742,207
Research focus
Tumor MarkersBackBeta-Glucosidase Stimulating ProteinResearch ProposalsTumorBloodBrain NeoplasmsCancer CellChemotherapyCoupledDrug Delivery SystemsExhibitsExtracellularGlioblastomaLabelLeadLipid BindingLipidsLipophilicityMalignant Neoplasm Of BrainMalignant NeoplasmsMouse ModelNanovesicleNeoplastic Cell